Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

FDA Approves a Nasal Antihistamine for Nonprescription Use
Thu, 17 Jun 2021 16:32:03 EDT

  FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.

FDA In Brief: FDA Announces Qualification of a Medical Device Development Tool to Help Assess Patient- Reported Outcomes with LASIK Surgery
Thu, 17 Jun 2021 13:41:21 EDT

  The FDA qualified a medical device development tool to help assess individuals’ symptoms and satisfaction with vision associated with LASIK surgery.

FDA In Brief: FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices
Thu, 17 Jun 2021 13:12:13 EDT

  The draft guidance should clarify “remanufacturing” and recommendations for labeling devices intended to be serviced over their useful life. A discussion paper outlining cybersecurity challenges and opportunities with the servicing was also released.

Coronavirus (COVID-19) Update: June 15, 2021
Tue, 15 Jun 2021 18:54:07 EDT

  Coronavirus (COVID-19) Update: June 15, 2021

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns
Tue, 15 Jun 2021 14:25:05 EDT

  FDA approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns).

Coronavirus (COVID-19) Update: June 11, 2021
Fri, 11 Jun 2021 16:08:38 EDT

  Coronavirus (COVID-19) Update: June 11, 2021

FDA Takes Steps to Increase Availability of COVID-19 Vaccine
Fri, 11 Jun 2021 11:19:36 EDT

  FDA authorized two batches of Janssen’s COVID-19 vaccine drug substance manufactured at the Emergent BioSolutions facility in Baltimore

FDA In Brief: FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials
Wed, 09 Jun 2021 11:21:16 EDT

  The FDA issued draft guidance to address which patient-reported outcomes concepts to measure in cancer clinical trials.

Coronavirus (COVID-19) Update: June 8, 2021
Tue, 08 Jun 2021 16:17:19 EDT

  Coronavirus (COVID-19) Update: June 8, 2021

FDA Grants Accelerated Approval for Alzheimer’s Drug
Mon, 07 Jun 2021 11:25:12 EDT

  The FDA approved a drug for the treatment of Alzheimer’s under the accelerated approval pathway, which can be used for a drug for a serious or life-threatening illness that provides meaningful therapeutic advantage over existing treatments.

FDA Approves First Treatment for Patients with Plasminogen Deficiency, a Rare Genetic Disorder
Fri, 04 Jun 2021 16:32:05 EDT

  FDA approved Ryplazim (plasminogen, human-tmvh) for the treatment of patients with type 1 plasminogen deficiency, also referred to as hypoplasminogenemia.

Coronavirus (COVID-19) Update: June 4, 2021
Fri, 04 Jun 2021 15:45:39 EDT

  Coronavirus (COVID-19) Update: June 4, 2021

FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014
Fri, 04 Jun 2021 14:17:48 EDT

  FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.

FDA In Brief: FDA provides new guidance to further enhance the security of prescription drugs in the U.S. supply chain
Thu, 03 Jun 2021 10:29:13 EDT

  FDA provides guidance to help ensure that prescription drugs are identified and traced properly as they move through the supply chain.

FDA Alerts Health Care Providers to Stop New Implants of Certain Ventricular Assist Device System
Thu, 03 Jun 2021 09:40:33 EDT

  FDA is alerting health care providers to no longer implant end-stage heart failure patients with Medtronic’s Heartware Ventricular Assist Device (HVAD) System.

FDA Authorizes Marketing of Diagnostic Aid for Autism Spectrum Disorder
Wed, 02 Jun 2021 11:09:31 EDT

  FDA has authorized marketing of a device to help diagnose autism spectrum disorder (ASD). The Cognoa ASD Diagnosis Aid is a machine learning-based software intended to help health care providers diagnose ASD in children 18 months through 5 years of age who exhibit potential symptoms.

Coronavirus (COVID-19) Update: June 1, 2021
Tue, 01 Jun 2021 16:36:37 EDT

  Coronavirus (COVID-19) Update: June 1, 2021

Nevada-Based Bottled Water Manufacturer Agrees to Stop Production for Failure to Comply with Manufacturing Requirements
Tue, 01 Jun 2021 15:47:03 EDT

  Nevada-Based Bottled Water Manufacturer Agrees to Stop Production for Failure to Comply with Manufacturing Requirements

FDA Launches Challenge to Spur Development of Affordable Traceability Tools as Part of Broader Food Safety Efforts
Tue, 01 Jun 2021 11:03:15 EDT

  FDA Launches Challenge to Spur Development of Affordable Traceability Tools as Part of Broader Food Safety Efforts

Coronavirus (COVID-19) Update: May 28, 2021
Fri, 28 May 2021 15:04:26 EDT

  Coronavirus (COVID-19) Update: May 28, 2021

Food and Drugs Administration--Recalls/Safety Alerts

Cuisine Solutions Issues Voluntary Recall of Flavored Plant-Based Bites
Sat, 19 Jun 2021 21:01:00 EDT

  Cuisine Solutions, Sterling, VA is initiating a voluntary recall of its JUST Egg flavored plant-based “bites” products due to undeclared allergens. A limited number of 2-pouch retail packages may contain an incorrect sealed pouch containing whole-egg and milk products. The interior plastic pouches

Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings
Wed, 16 Jun 2021 20:22:00 EDT

  Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels. Markings skewed approximately 20 degrees upward have been identified.

Designed By Nature Voluntarily Recalls Goat’s Milk, Cow’s Milk and Base Milk Formulas Due to Possible Health Risk
Mon, 14 Jun 2021 21:18:00 EDT

  DESIGNED BY NATURE of California is recalling our Goat’s Milk Powder, Cow’s Milk Powder and Base Milk Powder formulas with an expiration date between May 01, 2021 thru June 11, 2022. We intend to change our labeling to make it clear that these products are not intended to be used as infant formula

Philips Issues a Recall Notification* to Mitigate Potential Health Risks Related to the Sound Abatement Foam Component in Certain Sleep and Respiratory Care Devices
Mon, 14 Jun 2021 17:22:00 EDT

  Following the company update on April 26, 2021, Royal Philips(NYSE: PHG; AEX: PHIA) today provides an update on the recall notification* for specific Philips Bi-Level Positive Airway Pressure (Bi-Level PAP), Continuous Positive Airway Pressure (CPAP), and mechanical ventilator devices to address ide

Freshpet Voluntarily Recalls One Lot of Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food Due to Potential Salmonella Contamination
Sun, 13 Jun 2021 00:00:00 EDT

  Freshpet Inc. is announcing a voluntary recall of a single lot of Freshpet® Select Small Dog Bite Size Beef & Egg Recipe Dog Food (1 LB bags), with Sell by Date 10/30/2021, due to potential contamination with Salmonella. Our Freshpet Team had designated this single lot for destruction, but it was in

Viona Pharmaceuticals Inc., Issues Voluntary Nationwide Recall of Metformin HCl Extended-Release Tablets, USP 750 mg, Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Fri, 11 Jun 2021 00:00:00 EDT

  Viona Pharmaceuticals Inc., is voluntarily recalling 2 (two) lots of Metformin Hydrochloride Extended-Release Tablets, USP 750 mg to the retail level.

Purina Animal Nutrition Voluntarily Recalling One Lot of Purina® RangeLand® 30-13 (125#) Cattle Feed
Fri, 11 Jun 2021 00:00:00 EDT

  Purina Animal Nutrition is initiating a very limited voluntary recall of one lot of Purina® RangeLand® 30-13 (125#) beef cattle feed. This recall is being initiated as a precaution related to tubs that are too soft, allowing over-consumption, which could result in urea toxicity.

Tulkoff Food Products, Inc. Issues Allergy Alert on Undeclared (Soy and Wheat) in Kimchi Aioli
Tue, 08 Jun 2021 15:32:00 EDT

  Tulkoff Food Products Inc. of Baltimore Maryland is recalling Kimchi Aioli 18 fl. oz. squeeze bottles with lot code 09.18.2021M for the presence of undeclared wheat and soy allergens.

Hubbard Feeds Voluntarily Recalls Easy Feed Organic Chick Starter/Grower Org
Tue, 08 Jun 2021 00:00:00 EDT

  Hubbard Feeds is voluntarily recalling EASY FEED ORGANIC CHICK STARTER/GROWER ORG with batch number B01785781. The product has been found to contain deficient levels of salt.

Beech-Nut Nutrition Company Issues a Voluntary Recall of One Lot of Beech-Nut Single Grain Rice Cereal and Also Decides to Exit the Rice Cereal Segment
Tue, 08 Jun 2021 00:00:00 EDT

  Beech-Nut Nutrition today has issued a voluntary recall of one lot of Beech-Nut Stage 1, Single Grain Rice Cereal. This recall is a result of a routine sampling program by the State of Alaska which found that samples from that production lot of Beech-Nut Stage 1, Single Grain Rice Cereal tested abo

Smilin’ Bob’s Voluntarily Recalls Smilin’ Bob’s Smoked Fish Dip Products Because of Possible Health Risk
Mon, 07 Jun 2021 00:00:00 EDT

  Smilin’ Bob’s is voluntarily recalling Smilin’ Bob’s Original Smoked Fish Dip and Smilin’ Bob’s All Natural Smoked Fish Dip. This recall is being initiated as a result of the Banner Smoked Fish, Inc. recall of smoked fish due to possible contamination with Listeria monocytogenes. Smilin’ Bob’s used

Banner Smoked Fish Expends Recalls Smoked Fish Products, Salads, Pickled Fish Products, And Cream Sauce Products Because of Possible Health Risk
Fri, 04 Jun 2021 00:00:00 EDT

  Banner Smoked Fish, Inc. of Brooklyn, NY is voluntarily expending recalling its SMOKED FISH, SALADS, PICKLED FISH PRODUCTS, and CREAM SAUCE PRODUCTS (product names and photos of labels are listed below) of all products within expiry, in all package sizes, all package types and all lots. The recall i

Olde Thompson LLC Issues A Voluntary Recall of Olde Thompson And Sun Harvest Organic Ground Coriander Due to Possible Salmonella Risk
Fri, 04 Jun 2021 00:00:00 EDT

  Olde Thompson LLC. Oxnard, CA in cooperation with the FDA is recalling Olde Thompson and Sun Harvest Organic Ground Coriander in 1.5oz glass jar with flip top closure, Lot # 23632 and 23631 due to possible contamination by Salmonella.

Banner Smoked Fish Expands Recalls Smoked Fish Products, Salads, Pickled Fish Products, and Cream Sauce Products Because of Possible Health Risk
Thu, 03 Jun 2021 10:21:00 EDT

  Banner Smoked Fish, Inc. of Brooklyn, NY is voluntarily expending recalling its SMOKED FISH, SALADS, PICKLED FISH PRODUCTS, and CREAM SAUCE PRODUCTS (product names and photos of labels are listed below) of all products within expiry, in all package sizes, all package types and all lots. The recall i

Banner Smoked Fish Recalls Smoked Fish Products Because of Possible Health Risk
Wed, 02 Jun 2021 00:00:00 EDT

  Banner Smoked Fish, Inc. of Brooklyn, NY is voluntarily recalling its SMOKED FISH (product names and photos of labels are listed below) of all products within expiry, in all package sizes, all package types and all lots. The recall is because the products have the potential to be contaminated with L

Sunshine Mills, Inc. Issues Voluntary Recall of Certain Dog Food Products Because of Possible Salmonella Contamination
Wed, 02 Jun 2021 00:00:00 EDT

  Sunshine Mills, Inc. is issuing a voluntary recall of certain dog food products because of the potential to be contaminated with Salmonella. No illnesses, injuries or complaints have been reported to date. The potential for contamination was noted after the firm was notified by the distributor, Flee

Marquis Worldwide Specialty Inc. Recalls Organic Enoki Mushroom 200g Because of Possible Health Risk
Fri, 28 May 2021 21:39:00 EDT

  Marquis Worldwide Specialty Inc of City of Industry, CA is recalling All of the Organic Enoki Mushroom 200g, because it has the potential to be contaminated with Listeria monocytogenes, a bacterium which can cause life-threatening illness or death. Consumers are warned not to use the product even if

Rainfield Marketing Group, Inc. of Vernon, CA is Recalling Enoki Mushrooms (Product of Korea) Because it has the Potential to be Contaminated with Listeria monocytogenes
Fri, 28 May 2021 21:07:00 EDT

  Rainfield Marketing Group, Inc. of Vernon, CA is recalling all cases of its 150g packages of Enoki Mushrooms (Product of Korea) because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or

The Kroger Co. is Voluntarily Recalling its Chicken Street Taco Kit Due to Undeclared Egg
Fri, 28 May 2021 16:30:00 EDT

  The Kroger Co. is voluntarily recalling its Chicken Street Taco Kit due to a recall issued by its supplier Reser’s Fine Foods. These bulk kits have Chipotle Crema Sauce, which contains egg that was not declared on the label. Consumers who have an allergy or severe sensitivity to egg run the risk of

Sun Hong Foods, Inc. Recalls Seafood Mushroom Because of Possible Health Risk
Fri, 28 May 2021 00:00:00 EDT

  Sun Hong, Inc 1105 W Olympic Blvd, Montebello, CA 90640 is recalling All Cases of Seafood Mushroom (Product of China) Net Wt 5.3 oz./150g because it has the potential to be contaminated with Listeria monocytogenes, a bacterium which can cause life-threatening illness or death. Consumers are warned n

What's New: Drugs RSS Feed

Arthritis Advisory Committee Roster
Mon, 21 Jun 2021 10:43:11 EDT

  Advisory Committees (Drugs)

FDA’s Budget: Advancing the Goal of Ending the Opioid Crisis
Mon, 21 Jun 2021 10:37:04 EDT

  FDA’s FY 2022 budget request would address current public health needs and allow the agency to design programs intended to tackle complex challenges facing the country, such as those needed in addressing the opioid crisis.

FDA-Arthritis Foundation Osteoarthritis Drug Development Workshop: Assessment of Long-term Benefit - 06/22/2021 - 06/22/2021
Mon, 21 Jun 2021 09:37:13 EDT

  FDA-Arthritis Foundation Osteoarthritis Drug Development Workshop:
Assessment of Long-term Benefit



What's New Related to Drugs
Mon, 21 Jun 2021 06:19:45 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

Division of Applied Regulatory Science
Thu, 17 Jun 2021 16:59:56 EDT

  The Division of Applied Regulatory Science is located within FDA’s Office of Clinical Pharmacology and tackles emerging regulatory questions and develops and implements new regulatory review tools and approaches.

User Fee Lists
Thu, 17 Jun 2021 16:38:48 EDT

  Fiscal Year (FY) 2017 GDUFA facility fees are due on October 3, 2016.

FDA Approves a Nasal Antihistamine for Nonprescription Use
Thu, 17 Jun 2021 16:32:03 EDT

  FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch.

Prescription to Over-the-Counter (OTC) Switch List
Thu, 17 Jun 2021 16:26:01 EDT

  Prescription to Over-the-Counter (OTC) Switch List

CDER Small Business and Industry Assistance (SBIA) Learn
Thu, 17 Jun 2021 14:54:54 EDT

  SBIA Learn offers a variety of multimedia resources to provide information that is comprehensive, interactive, and easily accessible to small pharmaceutical business and industry.

Clinical Outcome Assessment Compendium
Thu, 17 Jun 2021 14:26:54 EDT

  FDA’s updated Clinical Outcome Assessment (COA) Compendium is now available. Serves as a communication tool between FDA and drug developers to encourage use of patient-focused COAs in clinical trials.

Premenopausal Women with Breast Cancer: Developing Drugs for Treatment
Thu, 17 Jun 2021 11:47:09 EDT

  This guidance provides recommendations to sponsors developing drugs or biological products regulated by CDER and CBER for the treatment of breast cancer.

Core Patient-Reported Outcomes in Cancer Clinical Trials
Thu, 17 Jun 2021 11:44:00 EDT

  This guidance provides recommendations to sponsors for collection of a core set of patient-reported clinical outcomes in cancer clinical trials and related considerations for instrument selection and trial design.

Generic Drug Facilities, Sites and Organization Lists
Thu, 17 Jun 2021 10:12:13 EDT

  Generic Drug Facilities, Sites and Organization Lists

Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)
Thu, 17 Jun 2021 08:59:14 EDT

  The Drug Information Soundcast in Clinical Oncology (DISCO) communicates key regulatory and safety aspects of oncology and hematology new drug approvals to the practicing oncologist, as well as other health care providers, consumers, pharmacists, and patient advocates in a concise and easily digestible format.

OPDP Form FDA 2253 and Request for Advisory Comment Submissions
Thu, 17 Jun 2021 08:26:27 EDT

  FDA Form 2253 submissions and requests for advisory comment submissions can be submitted to OPDP using eCTD or by sending paper copies.


FDA updates on hand sanitizers consumers should not use
Wed, 16 Jun 2021 17:16:20 EDT

  FDA Warns consumers and healthcare professionals of Hand Sanitizers contaminated with Methanol

CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
Wed, 16 Jun 2021 16:22:09 EDT

  CDER Scientific Reviews Supporting EUA for Therapeutic Products

FDA approves avapritinib for advanced systemic mastocytosis
Wed, 16 Jun 2021 16:03:21 EDT

  Oncology News Burst

Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Wed, 16 Jun 2021 15:44:31 EDT

  Oncology (Cancer) / Hematologic Malignancies Approval Notifications

Patent Certifications and Suitability Petitions
Wed, 16 Jun 2021 14:58:14 EDT

  Information on patents and suitability petitions that impact the availability of generic drugs.

Whats New Vaccines Blood Biologics RSS Feed

What’s New for Biologics
Mon, 21 Jun 2021 08:37:57 EDT

  Latest news from the Center for Biologics Evaluation and Research

BIMO/Team Biologics/Internet Surveillance/Other
Thu, 17 Jun 2021 15:51:13 EDT

  This is the main page for the CBER BIMO/Team Biologics/Internet Surveillance/Other.

Premenopausal Women with Breast Cancer: Developing Drugs for Treatment
Thu, 17 Jun 2021 11:47:09 EDT

  This guidance provides recommendations to sponsors developing drugs or biological products regulated by CDER and CBER for the treatment of breast cancer.

Core Patient-Reported Outcomes in Cancer Clinical Trials
Thu, 17 Jun 2021 11:44:00 EDT

  This guidance provides recommendations to sponsors for collection of a core set of patient-reported clinical outcomes in cancer clinical trials and related considerations for instrument selection and trial design.

CDER Scientific Review Documents Supporting Emergency Use Authorizations for Drug and Biological Therapeutic Products | COVID-19
Wed, 16 Jun 2021 16:22:09 EDT

  CDER Scientific Reviews Supporting EUA for Therapeutic Products

Janssen COVID-19 Vaccine
Wed, 16 Jun 2021 15:51:19 EDT

  Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson

Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays
Wed, 16 Jun 2021 09:14:16 EDT

  Links to the different types of Donor Screening Assays. A table for each assay is provided with detailed information such as tradename, infectious agent, format, specimen, use, manufacturer, approval date, and STN.

COVID-19 Vaccines
Tue, 15 Jun 2021 18:54:44 EDT

  FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

Coronavirus (COVID-19) Update: June 15, 2021
Tue, 15 Jun 2021 18:54:07 EDT

  Coronavirus (COVID-19) Update: June 15, 2021

STRATAGRAFT
Tue, 15 Jun 2021 16:42:13 EDT

  For the treatment of adults with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated (deep partial-thickness burns)

Approved Cellular and Gene Therapy Products
Tue, 15 Jun 2021 16:27:51 EDT

  Listing of licensed and approved products from the Office of Tissues and Advanced Therapies (OTAT).

Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs Frequently Asked Questions Statement of Investigator (Form FDA 1572) (Revision 1)
Tue, 15 Jun 2021 10:00:34 EDT

  Information Sheet Guidance
for Sponsors, Clinical Investigators, and IRBs

Frequently Asked Questions
Statement of Investigator
(Form FDA 1572) (Revision 1)


Have You Given Blood Lately?
Tue, 15 Jun 2021 09:35:25 EDT

  FDA works to ensure the safety of the more than 14 million units of blood and blood components donated in the U.S. each year. Learn how FDA helps safeguard the blood supply and how you can donate blood.

ADYNOVATE
Tue, 15 Jun 2021 08:22:19 EDT

  Product approval information is indicated for children and adults with hemophilia A (congenital factor VIII deficiency) for: (1) On-demand treatment and control of bleeding episodes; (2) Perioperative management; (3) Routine prophylaxis to reduce the frequency of bleeding episodes.

Consumer Updates
Mon, 14 Jun 2021 14:05:39 EDT

  Science-based health and safety information you can trust.

Human Cell and Tissue Establishment Registration (HCTERS) Public Query Application
Mon, 14 Jun 2021 10:09:31 EDT

  Welcome to the Human Cell and Tissue Establishment Registration (HCTERS) Public Query application. You may use this application to review Human Cell and Tissue registration information for registered, inactive, and pre-registered firms.

Pfizer-BioNTech COVID-19 Vaccine
Fri, 11 Jun 2021 20:11:47 EDT

  Information about the Pfizer-BioNTech COVID-19 vaccine

KYMRIAH (tisagenlecleucel)
Fri, 11 Jun 2021 18:22:17 EDT

  KYMRIAH is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse

Labeling and Promotion Guidances
Fri, 11 Jun 2021 11:56:03 EDT

  This page lists Labeling and Promotion Guidance documents.

Testing for Biotin Interference in In Vitro Diagnostic Devices
Fri, 11 Jun 2021 10:56:11 EDT

  Testing for Biotin Interference in In Vitro Diagnostic Devices, Guidance for Industry, Final, CBER, Biologics





See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.





 
 

Contact Us


Corporate Headquarters


Practical Compliance Solutions
One Orient Way
Suite F156
Rutherford, NJ 07070
  201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2021 - Copyright Practical Compliance Solutions - All rights reserved